DR AGARWALS HEALTH CARE
|
DR AGARWALS HEALTH CARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.64 | 89.02 | 118.72 | 54.95 | -80.87 |
| CEPS(Rs) | 10.80 | 9.48 | 9.74 | 6.84 | 1.77 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 58.77 | 1,428.99 | 791.99 | 309.59 | 268.57 |
| Tax Rate(%) | 30.97 | 32.38 | -23.49 | 23.96 | -20.75 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 26.39 | 27.18 | 26.51 | 26.10 | 16.29 |
| EBIT Margin(%) | 16.07 | 18.10 | 15.73 | 15.19 | -0.90 |
| Pre Tax Margin(%) | 9.34 | 10.55 | 8.21 | 8.15 | -10.26 |
| PAT Margin (%) | 6.45 | 7.14 | 10.14 | 6.20 | -12.39 |
| Cash Profit Margin (%) | 19.93 | 19.92 | 22.74 | 20.23 | 7.72 |
| Performance Ratios | |||||
| ROA(%) | 3.47 | 4.24 | 7.42 | 4.83 | -7.71 |
| ROE(%) | 6.92 | 9.69 | 24.58 | 21.77 | -26.95 |
| ROCE(%) | 14.32 | 17.77 | 21.51 | 24.26 | -1.09 |
| Asset Turnover(x) | 0.54 | 0.59 | 0.73 | 0.78 | 0.62 |
| Sales/Fixed Asset(x) | 0.59 | 0.64 | 0.71 | 0.72 | 0.59 |
| Working Capital/Sales(x) | 5.41 | 3.71 | 114.88 | 32.41 | 116.72 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.69 | 1.57 | 1.41 | 1.39 | 1.69 |
| Receivable days | 23.51 | 23.72 | 23.85 | 27.12 | 38.40 |
| Inventory Days | 14.10 | 12.05 | 12.36 | 15.94 | 23.75 |
| Payable days | 322.00 | 312.42 | 306.23 | 356.83 | 419.56 |
| Valuation Parameters | |||||
| PER(x) | 169.15 | - | - | - | - |
| PCE(x) | 41.39 | - | - | - | - |
| Price/Book(x) | 7.60 | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 8.24 | 0.20 | 0.21 | 0.26 | 0.27 |
| EV/Core EBITDA(x) | 27.73 | 0.66 | 0.75 | 0.89 | 1.40 |
| EV/EBIT(x) | 51.29 | 1.13 | 1.35 | 1.71 | -29.82 |
| EV/CE(x) | 6.67 | 0.16 | 0.22 | 0.36 | 0.34 |
| M Cap / Sales | 8.25 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 28.44 | 30.86 | 46.25 | 47.73 | -11.23 |
| Core EBITDA Growth(%) | 23.65 | 42.68 | 41.77 | 124.82 | -33.69 |
| EBIT Growth(%) | 14.07 | 50.61 | 51.37 | 2,580.75 | -109.84 |
| PAT Growth(%) | 16.09 | -7.92 | 139.16 | 173.94 | -197.11 |
| EPS Growth(%) | -97.03 | -25.01 | 116.06 | 167.94 | -170.22 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.13 | 0.29 | 0.57 | 1.37 | 1.01 |
| Current Ratio(x) | 1.66 | 1.90 | 1.03 | 1.10 | 1.03 |
| Quick Ratio(x) | 1.49 | 1.77 | 0.91 | 0.94 | 0.84 |
| Interest Cover(x) | 2.39 | 2.40 | 2.09 | 2.16 | -0.10 |
| Total Debt/Mcap(x) | 0.02 | - | - | - | - |
Compare Financial Ratios of peers of DR AGARWALS HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR AGARWALS HEALTH CARE | ₹15,193.8 Cr | 7.8% | 3.9% | 19.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹120,200.0 Cr | 4.2% | 9.1% | 19% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹99,587.2 Cr | -3.3% | 1.8% | -8.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹72,510.0 Cr | -0.2% | 4% | 41.1% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹39,185.5 Cr | 0.2% | 10.5% | 29.8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,895.6 Cr | -0.7% | 2.3% | 10.1% | Stock Analytics | |
DR AGARWALS HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR AGARWALS HEALTH CARE | 7.8% |
3.9% |
19.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses
